[1]
“MUCORMYCOSIS OUTCOMES IN THE COVID 19 ERA: A RETROSPECTIVE COHORT STUDY”, Northwest J Med Sci, vol. 4, no. 4, pp. 43–47, Dec. 2025, doi: 10.69723/njms.04.04.0633.